Reached an alignment with FDA on Phase 2/3 pivotal confirmatory clinical trial for OCU410ST for Stargardt disease potentially expediting clinical ...

Development of CRG-023 and allogeneic platform suspended; further reduction in force (RIF) of approximately 90% to preserve cash and maximize ...

Proficio Capital Partners LLC raised its holdings in Lam Research Co. (NASDAQ:LRCX – Free Report) by 966.8% during the fourth ...

In a new study published in Engineering, researchers from Huazhong University of Science and Technology and the Technical ...

In today's rapidly evolving threat landscape, cybersecurity is more crucial than ever. Advanced persistent threats (APTs) and ...

BrandAlley, a UK-based designer and luxury fashion online retailer, has over eight million members, adds thousands of new ...

W hen Musk and his allies turned their attention to the FAA last month, they identified a problem: The communications ...

Eric Siegel, a Ph.D. student in microbiologist Stephen Rich’s Laboratory of Medical Zoology and at the UMass Amherst-based New England Center of Excellence in Vector-borne Diseases (NEWVEC), has been ...

Victor Basta, Managing Partner of Artis Partners, believes we may be in the midst of the next round of "Zombie Unicorns." ...

In addition, the Philippines Thrust Vector Control Market study demonstrates a detailed ... Their goal is to assist clients in achieving their top line and bottom line objectives, thereby enhancing ...

Ukraine has considerable leverage in upcoming negotiations with Russia—as long as the United States stands by Kyiv and adopts a negotiating strategy that creates real dilemmas for Moscow. U.S. support ...

Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.